BRIEF published on 06/03/2026 at 00:05, 2 months 10 days ago Onco-Innovations Achieves Key Milestone in ONC010 Manufacturing Clinical Development ONC010 Manufacturing B4 Precursor Production Dalton Pharma Collaboration Market Awareness Strategy
BRIEF published on 06/03/2026 at 00:05, 2 months 10 days ago Onco-Innovations franchit une étape clé dans la fabrication de l'ONC010 Développement Clinique Fabrication ONC010 Production Du Précurseur B4 Collaboration Avec Dalton Pharma Stratégie De Sensibilisation Au Marché
BRIEF published on 06/02/2026 at 22:40, 2 months 10 days ago Hycroft Reports $10 Billion NPV Amidst New Silver Discoveries Technical Report NPV Gold And Silver Prices Hycroft Mining Silver Discoveries
BRIEF published on 06/02/2026 at 22:40, 2 months 10 days ago Hycroft annonce une VAN de 10 milliards de dollars grâce à de nouvelles découvertes d'argent Rapport Technique Prix De L'or Et De L'argent Hycroft Mining VAN Découvertes D'argent
BRIEF published on 06/02/2026 at 22:35, 2 months 10 days ago INEO Tech Corp. Announces Share Consolidation Details TSX Venture Exchange Share Consolidation Equity Conversion Financing Plan INEO Tech Corp.
BRIEF published on 06/02/2026 at 22:35, 2 months 10 days ago INEO Tech Corp. annonce les détails de son regroupement d'actions Bourse De Croissance TSX Plan De Financement Regroupement D'actions Conversion D'actions INEO Tech Corp.
BRIEF published on 06/02/2026 at 22:35, 2 months 10 days ago Nanobiotix Reports Q1 2026 Operational and Financial Progress NSCLC Financial Update NANOBIOTIX JNJ-1900 AACR 2026
BRIEF published on 06/02/2026 at 22:35, 2 months 10 days ago Nanobiotix annonce ses progrès opérationnels et financiers pour le premier trimestre 2026. Mise À Jour Financière NANOBIOTIX JNJ-1900 AACR 2026 CBNPC
BRIEF published on 06/02/2026 at 22:35, 2 months 10 days ago Nanobiotix : Bilan du premier trimestre 2026 Biotechnologie Augmentation De Capital Essais Cliniques Nanotechnologie NBTXR3
BRIEF published on 06/02/2026 at 22:35, 2 months 10 days ago Nanobiotix: Review of the first quarter of 2026 Biotechnology Clinical Trials Capital Increase Nanotechnology NBTXR3
Published on 08/12/2026 at 23:30, 4 hours 58 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 4 hours 58 minutes ago Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 5 hours 8 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 5 hours 23 minutes ago Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/13/2026 at 02:00, 2 hours 28 minutes ago A New Category Is Emerging in the Premium Residential Market — the 'Presidence'
Published on 08/13/2026 at 01:05, 3 hours 23 minutes ago Pepperstone Appoints New CTO to Drive AI-Native Proprietary Tech Push
Published on 08/12/2026 at 21:05, 7 hours 23 minutes ago Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 8 hours 31 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 8 hours 51 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/11/2026 at 17:45, 1 day 10 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 10 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 10 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 10 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
